Markets & Regulations

Celltech lays claims to OGS

Celltech lays claims to OGS

UK biotechnology bellwether Celltech has emerged victorious in the
bidding battle for Oxford GlycoSciences. OGS reluctantly gave in to
Celltech's pressure on 11 April, after the latter firm bought
additional holdings which brought...

HQ for Euro biotech

HQ for Euro biotech

The European Federation of Biotechnology (EFB) is setting up a
trade office in Aarhus, Denmark for its activities in innovation
and functional genomics, reports Biotech Denmark on its website.

Osmetch grows

Osmetch grows

UK developer of medical diagnostics devices Osmetech continued the
strategy to build on its healthcare diagnostics business with the
acquisition this week of the Atlanta-based 'OPTI' product line of
blood gas analysers owned...

New patent for Chiral Quest

New patent for Chiral Quest

Life science company Chiral Quest this week announced that the
non-profit organisation, the Penn State Research Foundation, has
received a US patent covering the compositions of matter and use
for a series of chiral phosphine ligands...

UK biotech collaboration

UK biotech collaboration

Two British firms, De Novo Pharmaceuticals and Peakdale Molecular,
are to enter into a joint collaboration to exploit their respective
skills in molecular design and chemistry synthesis, writes market
analysts Datamonitor this week.

New era for Roche

New era for Roche

Shareholders at Swiss pharmaceutical company Roche welcomed the
start of a new era as the company summarised recent events,
including the divestment of the vitamins business, at its annual
general meeting yesterday.

Biogen digs into Europe

Biogen digs into Europe

Biotechnology company Biogen this week celebrated its 25th
anniversary by breaking the ground on a large-scale manufacturing
facility in Hillerød, Denmark, marking the company's first
development phase for the region and a greater...

Xenogen in Japan

Xenogen in Japan

SC Biosciences is to be the exclusive distributor of sensitive
tools for drug discovery with the announcement this week that it
will distribute in vivo imaging technology in Japan for US company
Xenogen corporation.

Softly, softly...

Softly, softly...

German pharmaceutical company Boehringer Ingelheim has signed a
long-term agreement with software company MDL Information Systems
to use its software technology for managing and deploying chemical
information systems.

Fund setback for world leader

Fund setback for world leader

Applied Biosystems group, the world's number one maker of
gene-analysing equipment, warned on Tuesday that it would report
lower-than-expected fiscal third-quarter revenue and earnings due
to deteriorating business conditions.

Asia-Pacfic focus

Asia-Pacfic focus

Singapore is the location for the first 'Drug Discovery Technology'
event organised by IBC Life Sciences in the Asia-Pacific region.

IVAX remains 'active'

IVAX remains 'active'

Pharmaceutical and veterinary product manufacturer IVAX corporation
has acquired ChemSource, a manufacturer of active pharmaceutical
ingredients based in Puerto Rico.

Rhodia losses

Rhodia losses

French specialty chemicals company Rhodia today reported net sales
of €6,617 million in 2002, representing a nine per cent drop
compared with 2001.

Degussa divestments complete

Degussa divestments complete

German chemicals company Degussa has sold its Frankfurt/Main-based
biopharmaceutical company Zentaris to Canadian firm AEterna
Laboratories for approximately €50 million, the company said last
week. The move marks the much-talked...